Status:
COMPLETED
Radioguided Occult Lesion Localisation by Indocyanine Green
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Breast cancer is the most common cancer in women. It is the main cause of cancer deaths among women. The incidence of non-palpable tumors is estimated at 60%. Their better prognosis and their small si...
Detailed Description
The study is prospectively conducted during six months of 2017-2018 in the department of gynaecology of Montpellier . This study includes ten women. Patients will receive both techniques: indocyanine...
Eligibility Criteria
Inclusion
- Woman Age ≥ 18 years
- Non-palpable tumor
- Single tumor
- First breast surgery
- Histology: ductal carcinoma
- Written consent
- Being affiliated or benefiting from a French social security system
Exclusion
- palpable tumor
- multifocal tumor
- antecedent of breast surgery
Key Trial Info
Start Date :
October 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03313908
Start Date
October 17 2017
End Date
December 19 2018
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Montpellier
Montpellier, France, 34295